Hematologia
Tromboottinen trombosytopeeninen purppura (TTP)
Successful management of a Jehovah's Witness with thrombotic thrombocytopenic purpura unwilling to be treated with therapeutic plasma exchange. (avaa uuden ikkunan)
Lähde: J Clin Apher 2007;22(6):330-2.
Arkistoitu: PubMed 18080270
DOI: 10.1002/jca.20150
https://www.ncbi.nlm.nih.gov/pubmed/18080270 (avaa uuden ikkunan)
Assessment and monitoring of patients with immune-mediated thrombotic thrombocytopenic purpura (iTTP): strategies to improve outcomes. (avaa uuden ikkunan)
Lähde: J Blood Med 2020;11:319-26.
Arkistoitu: PubMed 33061729
DOI: 10.2147/JBM.S205630
https://www.ncbi.nlm.nih.gov/pubmed/33061729 (avaa uuden ikkunan)
Therapeutic modalities in thrombotic thrombocytopenic purpura management among Jehovah's Witness patients: a review of reported cases. (avaa uuden ikkunan)
Lähde: Transfus Apher Sci. 2023;62(4):103706. Epub 2023 Mar 21.
Arkistoitu: PubMed 36990894
DOI: 10.1016/j.transci.2023.103706
https://pubmed.ncbi.nlm.nih.gov/36990894/ (avaa uuden ikkunan)
Thrombotic thrombocytopenic purpura treated with vincristine in a Jehovah's Witness. (avaa uuden ikkunan)
Lähde: Asian J Transfus Sci 2011;5(2):180-1.
Arkistoitu: PubMed 21897605
DOI: 10.4103/0973-6247.83255
https://www.ncbi.nlm.nih.gov/pubmed/21897605 (avaa uuden ikkunan)